Home › Calculator › PPBT Dividend Calculator 2026
PPBT Dividend DRIP Calculator 2026
139.86% YieldHealthcarePurple Biotech Ltd. · NASDAQ
Price: $1.43 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PPBT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PPBT snowball 📈
$10,000 in PPBT → $19167979325342.62M in 10 years · $1,596,217,064,350,481,700.00/month
About Purple Biotech Ltd. (PPBT) — Dividend Analysis 2026
Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). This candidate is undergoing Phase 1b/2 clinical trials, where it is being evaluated as a combination therapy with anti-PD-1 checkpoint inhibitors for non-small cell lung cancer and pancreatic cancer. NT219: A small molecule compound that targets insulin receptor substrate 1 and 2 (IRS1/2) as well as signal transducer and activator of transcription (STAT) pathways. NT219 is currently in Phase 1/2 clinical studies for the treatment of recurrent or metastatic solid tumors and squamous cell carcinoma of the head and neck. The company was formerly known as Kitov Pharma Ltd until its rebranding to Purple Biotech Ltd. in December 2020.
Compare PPBT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PPBT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PPBT position with:
🌍 PPBT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PPBT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 139.86% | 137.06% | $13,986 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 118.88% | 116.08% | $11,888 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 111.89% | 109.09% | $11,189 / yr |
| 🇬🇧 UK ISA | 0% | 139.86% | 137.06% | $13,986 / yr |
| 🇬🇧 UK Taxable | 8.75% | 127.62% | 124.82% | $12,762 / yr |
| 🇨🇦 TFSA | 0% | 139.86% | 137.06% | $13,986 / yr |
| 🇨🇦 CA Taxable | 25% | 104.90% | 102.10% | $10,490 / yr |
| 🇦🇺 Super (pension) | 15% | 118.88% | 116.08% | $11,888 / yr |
| 🇦🇺 AU Taxable | 30% | 97.90% | 95.10% | $9,790 / yr |
| 🇩🇪 DE Taxable | 26.375% | 102.97% | 100.17% | $10,297 / yr |
| 🇫🇷 FR Taxable | 30% | 97.90% | 95.10% | $9,790 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PPBT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PPBT Dividend Payment Schedule
PPBT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 PPBT vs Healthcare Benchmarks
How PPBT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PPBT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PPBT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2026-03-18 | 2,650,000 | — | — | ||
| Other | 2026-03-18 | 2,650,000 | — | — | ||
| Other | 2026-03-18 | 2,650,000 | — | — | ||
| Other | 2026-03-18 | 13,500,000 | — | — | ||
| Other | 2026-03-18 | 7,100,000 | — | — | ||
| Other | 2026-03-18 | 3,550,000 | — | — | ||
| Other | 2026-03-18 | 2,650,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PPBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Purple Biotech Ltd. (PPBT) is currently trading at $1.43, trading near its 52-week low. The current dividend yield is 139.86% based on an annual payout of $2.00 per share.
PPBT (Purple Biotech Ltd.) — 139.86% Dividend Yield Analysis
Purple Biotech Ltd. (PPBT) is a healthcare stock currently trading at $1.43 with a dividend yield of 139.86%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (139.86%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.